Clinical trial
Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
NCT01375699
Study timeline
Study start (actual)2011-08-11Date precision: day
Registry last updated2019-08-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Gastrointestinal Cancerunresolved
Genitourinary Cancerunresolved
Sarcomaunresolved
Gynecologic Cancerunresolved
Interventions
DoxorubicinDRUG · verified · RxNorm: doxorubicin
SildenafilDRUG · verified · RxNorm: sildenafil
Sponsors & collaborators
Virginia Commonwealth Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01375699 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.